SCHEMBL18154561

SCHEMBL18154561

O=c1cc(OCc2ccc(Cl)cn2)ccn1-c1ccc2c(c1)cc1n2CCN(CC2CC2)CC1

nearest known ligand 0.54

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 19/20 0.54
CYP3A4 P08684 1/20 0.39
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18154521 0.90 MCHR1 (0.54) MCHR1
SCHEMBL30701057 0.90 MCHR1 (0.54) MCHR1
SCHEMBL18154563 0.87 MCHR1 (0.55) MCHR1
SCHEMBL30701156 0.86 MCHR1 (0.57) MCHR1
SCHEMBL18154534 0.86 MCHR1 (0.57) MCHR1
SCHEMBL18154554 0.86 MCHR1 (0.55) MCHR1
Fumaric Acid SCHEMBL18154566 0.84 MCHR1 (0.49) MCHR1CYP3A4KCNH2
Maleic Acid SCHEMBL18154565 0.84 MCHR1 (0.49) MCHR1CYP3A4KCNH2
SCHEMBL18154574 0.84 MCHR1 (0.54) MCHR1
SCHEMBL18154522 0.83 MCHR1 (0.62) MCHR1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3286193-B1 INDOLE DERIVATIVES RICHTER GEDEON NYRT (HU) 2020-05-27 EP claimed
US-10329296-B2 Indole derivatives RICHTER GEDEON NYRT. (HU) 2019-06-25 US claimed
EP-3286193-B1 INDOLE DERIVATIVES RICHTER GEDEON NYRT (HU) 2020-05-27 EP disclosed
EP-3286193-A1 INDOLE DERIVATIVES Richter Gedeon Nyrt. (HU) 2018-02-28 EP disclosed
WO-2016166684-A1 INDOLE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2016-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329296-B2 Indole derivatives TPH1, MCHR1, MC1R MCHR1 2/4885CYP3A4 348/4885KCNH2 2003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.